Moderna Inc
NASDAQ:MRNA
Moderna Inc
Net Issuance of Debt
Moderna Inc
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Moderna Inc
NASDAQ:MRNA
|
Net Issuance of Debt
-$246m
|
CAGR 3-Years
-213%
|
CAGR 5-Years
-201%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Debt
$12.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
181%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Debt
$2.6B
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Debt
-$45.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
4%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Moderna Inc's Net Issuance of Debt?
Net Issuance of Debt
-246m
USD
Based on the financial report for Mar 31, 2024, Moderna Inc's Net Issuance of Debt amounts to -246m USD.
What is Moderna Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
-201%
Over the last year, the Net Issuance of Debt growth was -38%. The average annual Net Issuance of Debt growth rates for Moderna Inc have been -213% over the past three years , -201% over the past five years .